Related Experiment Video
Updated: May 27, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process
Balázs Koscsó1, Balázs Csóka, Zsolt Selmeczy
1Department of Surgery, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA.
Abstract:
Microglia are activated by pathogen-associated molecular patterns and produce proinflammatory cytokines, such as TNF-α, IL-6, and IL-12, and the anti-inflammatory cytokine IL-10. Adenosine is an endogenous purine nucleoside and a ligand of four G protein-coupled adenosine receptors (ARs), which are the A(1)AR, A(2A)AR, A(2B)AR, and A(3)AR. ARs have been shown to suppress TNF-α production by microglia, but their role in regulating IL-10 production has not been studied. In this study, we demonstrate that adenosine augments IL-10 production by activated murine microglia while suppressing the production of proinflammatory cytokines. Because the order of potency of selective AR agonists in inducing IL-10 production was NECA > IB-MECA > CCPA ≥ CGS21680, and the A(2B)AR antagonist MRS1754 prevented the effect of NECA, we conclude that the stimulatory effect of adenosine on IL-10 production is mediated by the A(2B)AR. Mechanistically, adenosine augmented IL-10 mRNA accumulation by a transcriptional process. Using mutant IL-10 promoter constructs we showed that a CREB-binding region in the promoter mediated the augmenting effect of adenosine on IL-10 transcription. Chromatin immunoprecipitation analysis demonstrated that adenosine induced CREB phosphorylation at the IL-10 promoter. Silencing CREB using lentivirally delivered short hairpin RNA blocked the enhancing effect of adenosine on IL-10 production, confirming a role for CREB in mediating the stimulatory effect of adenosine on IL-10 production. In addition, adenosine augmented IL-10 production by stimulating p38 MAPK. Collectively, our results establish that A(2B)ARs augment IL-10 production by activated murine microglia.
Insights
Adenosine boosts anti-inflammatory IL-10 production in activated microglia via the A(2B) adenosine receptor (AR). This mechanism involves CREB activation and p38 MAPK signaling, while suppressing proinflammatory cytokines.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Microglia, the immune cells of the central nervous system, produce pro-inflammatory and anti-inflammatory cytokines.
- Adenosine receptors (ARs) are known to modulate microglial pro-inflammatory cytokine production.
- The role of ARs in regulating the anti-inflammatory cytokine IL-10 in microglia remains uncharacterized.
Purpose of the Study:
- To investigate the effect of adenosine on IL-10 production in activated murine microglia.
- To identify the specific adenosine receptor subtype mediating this effect.
- To elucidate the molecular mechanisms underlying adenosine-induced IL-10 production.
Main Methods:
- Primary murine microglia activation and treatment with adenosine and AR agonists/antagonists.
- Quantitative analysis of IL-10 and pro-inflammatory cytokine production (e.g., TNF-α, IL-6).
- Adenosine receptor subtype identification using selective agonists and antagonists.
- Investigation of molecular pathways including mRNA accumulation, promoter activity assays, CREB phosphorylation, and p38 MAPK activation.
Main Results:
- Adenosine significantly augmented IL-10 production in activated microglia.
- Adenosine suppressed the production of pro-inflammatory cytokines (TNF-α, IL-6, IL-12).
- The A(2B)AR was identified as the primary receptor mediating adenosine's effect on IL-10 production.
- Adenosine-induced IL-10 production involved transcriptional regulation via CREB activation and p38 MAPK signaling.
Conclusions:
- Adenosine, acting through the A(2B)AR, enhances IL-10 production in activated microglia.
- This effect is mediated by transcriptional upregulation of IL-10 involving CREB and p38 MAPK pathways.
- Adenosine's dual action of increasing IL-10 while decreasing pro-inflammatory cytokines suggests a potent immunomodulatory role in the brain.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Desensitization and Tachyphylaxis
Several...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

